Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Louis Grasmick Insider Profile
4 Followers
Louis Grasmick, Director at Capricor Therapeutics, holds 1.05M shares in Capricor Therapeutics (Ticker: CAPR). Most recently, Louis Grasmick Bought $91,369 shares of Capricor Therapeutics on Mar 18, 2016 for an estimated value of 219.29K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-7.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Louis Grasmick holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 18, 2016 - Mar 18, 2017
Return:+26.90%
The most profitable trade made by Louis Grasmick
Louis Grasmick's Trading History
List of latest transactions for each holding click on a transaction to see Louis Grasmick's performance on stock
You May Also Like
Louis Grasmick insider profile FAQ
What is the percentage of profitable transactions made by Louis Grasmick?
The percentage of profitable transactions made by Louis Grasmick is 33%.
What is the average return per transaction made by Louis Grasmick?
The average return per transaction made by Louis Grasmick is -7.50%.
What stocks does Louis Grasmick hold?
Louis Grasmick holds: CAPR stocks.
What was Louis Grasmick’s latest transaction?
Louis Grasmick latest transaction was an Informative Buy of $219.29K.
What was Louis Grasmick's most profitable transaction?
Louis Grasmick’s most profitable transaction was an Informative Buy of CAPR stock on March 18, 2016. The return on the trade was 26.90%.
What is Louis Grasmick's role in Capricor Therapeutics?
Louis Grasmick's role in Capricor Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.